EXTERNAL VALIDATION OF THE PROGRESS-CTO COMPLICATION RISK SCORES: INDIVIDUAL PATIENT DATA POOLED ANALYSIS OF 3 REGISTRIES
Bahadir Simsek(Yale New Haven Hospital), Lorenzo Azzalini(Abbott Northwestern Hospital), J. Aaron Grantham(Saint Luke's Hospital), Bavana V. Rangan(Minneapolis Heart Institute Foundation), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Paul Knaapen(Amsterdam University Medical Centers), Jaikirshan Khatri(Cleveland Clinic), Kambis Mashayekhi(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Spyridon Kostantinis(Yale New Haven Hospital), James Spratt(St George's, University of London), Ilias Nikolakopoulos(University of California, San Francisco), Evangelia Vemmou(Abbott Northwestern Hospital), Kathleen E. Kearney(University of Washington), Péter Tajti(Southwestern Medical Center), Stéphane Rinfret(Montreal Heart Institute), Ömer Göktekín(Istanbul Memorial Hospital), Alessio La Manna(Marconi University), Piergiuseppe Agostoni(University of Milan), Mauro Carlino(San Raffaele University of Rome), Khaldoon Alaswad(Ford Motor Company (United States)), Michael Megaly(St. John Medical Center), Alexandre Avran(Institut Arnault Tzanck), Emmanouil S. Brilakis(Minneapolis Heart Institute Foundation), William Lombardi(University of Washington), Judit Karácsonyi(University of Utah)
Cited by 1
Related Papers
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
|The Lancet|2020|586
Anatomic Versus Physiologic Assessment of Coronary Artery Disease
|Journal of the American College of Cardiology|2013|563